Roles of diacylglycerols and ceramides in hepatic insulin resistance

Cited by (373)

Items 101–200 of 373

1. Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage
   Audrey Sambeat, Joanna Ratajczak, Magali Joffraud, José L. Sanchez-Garcia, Maria Pilar Giner, Armand Valsesia, Judith Giroud‐Gerbetant, Miriam Valera‐Alberni, Angelique Cercillieux, Marie Boutant et al. · 2019 · Nature Communications
2. Role of fatty acid elongase Elovl6 in the regulation of energy metabolism and pathophysiological significance in diabetes
   Takashi Matsuzaka · 2020 · Diabetology International
3. In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia
   Martina Hüttl, Irena Marková, Denisa Miklánková, Iveta Zapletalová, Martin Poruba, Martin Haluzı́k, Ivana Vaněčková, Hana Malínská · 2021 · International Journal of Molecular Sciences
4. Overnutrition, Hyperinsulinemia and Ectopic Fat: It Is Time for A Paradigm Shift in the Management of Type 2 Diabetes
   J. A. M. J. L. Janssen · 2024 · International Journal of Molecular Sciences
5. Regulation of hepatic insulin signaling and glucose homeostasis by sphingosine kinase 2
   Gulibositan Aji, Yu Huang, Mei Li Ng, Wei Wang, Tian Lan, Min Li, Yufei Li, Qi Chen, Rui Li, Sishan Yan et al. · 2020 · Proceedings of the National Academy of Sciences
6. The role of adipose triglyceride lipase in lipid and glucose homeostasis: lessons from transgenic mice
   Michael J. Trites, Robin D. Clugston · 2019 · Lipids in Health and Disease
7. Small-Molecule Inhibitors Targeting Lipolysis in Human Adipocytes
   Gernot F. Grabner, Nikolaus Guttenberger, Nicole Mayer, Anna Katharina Migglautsch, Christian Lembacher‐Fadum, Nermeen Fawzy, Dominik Bulfon, Peter Hofer, Thomas Züllig, Lennart Hartig et al. · 2022 · Journal of the American Chemical Society
8. Switching obese mothers to a healthy diet improves fetal hypoxemia, hepatic metabolites, and lipotoxicity in non-human primates
   Stephanie R. Wesolowski, C. Mulligan, R. Janssen, Peter R. Baker, B. Bergman, A. D'Alessandro, T. Nemkov, K. Maclean, Hua Jiang, T. Dean et al. · 2018 · Molecular Metabolism
9. Short-term strength training reduces gluconeogenesis and NAFLD in obese mice
   Rodrigo Martins Pereira, Kellen Cristina da Cruz Rodrigues, Chadi Pellegrini Anaruma, Marcella Ramos Sant’Ana, Thaís Dantis Pereira de Campos, Rodrigo S. Gaspar, Raphael dos Santos Canciglieri, Diego Gomes de Melo, Rania A. Mekary, Adelino Sánchez Ramos da Silva et al. · 2019 · Journal of Endocrinology
10. Impact of high-intensity interval training and sprint interval training on peripheral markers of glycemic control in metabolic syndrome and type 2 diabetes
    Alberto Jiménez‐Maldonado, Patricia C. García‐Suárez, Iván Rentería, José Moncada‐Jiménez, Eric P. Plaisance · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
11. The ketogenic diet prevents steatosis and insulin resistance by reducing lipogenesis, diacylglycerol accumulation and protein kinase C activity in male rat liver
    Shailee Jani, Daniel Da Eira, Mateja Stefanovic, Rolando Bacis Ceddia · 2022 · The Journal of Physiology
12. Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity
    G. Marín-Royo, I. Gallardo, E. Martínez-Martínez, B. Gutiérrez, R. Jurado-López, N. López-Andrés, Josué Gutiérrez-Tenorio, E. Rial, M. Bartolomé, M. Nieto et al. · 2018 · Disease Models & Mechanisms
13. Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography
    Alessandro Mantovani, Stefano Bonapace, G Lunardi, Guido Canali, Clementina Dugo, Giulia Vinco, Stefano Calabria, Erika Barbieri, Reijo Laaksonen, Fabrice Bonnet et al. · 2019 · Diabetes & Metabolism
14. Electrophilic nitro-oleic acid reverses obesity-induced hepatic steatosis
    Nicholas K.H. Khoo, Marco Fazzari, Dionysios V. Chartoumpekis, Lihua Li, Danielle Aparecida Guimarães, Gavin E. Arteel, Sruti Shiva, Bruce Α. Freeman · 2019 · Redox Biology
15. Uncoupling hepatic insulin resistance – hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 diabetes
    SITARA NIRANJAN, Brett Eugene Phillips, Nick Giannoukakis · 2023 · Frontiers in Endocrinology
16. Biochemical and immunological changes in obesity
    Beatriz Barakat, Martha Elisa Ferreira de Almeida · 2021 · Archives of Biochemistry and Biophysics
17. Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma
    Marcin Kosmalski, Agnieszka Śliwińska, Józef Drzewoski · 2023 · Biomedicines
18. Ginsenoside Rg5 relieves type 2 diabetes by improving hepatic insulin resistance in db/db mice
    Yange Wei, Haixia Yang, Chenhui Zhu, Jianjun Deng, Daidi Fan · 2020 · Journal of Functional Foods
19. Kukoamine B Ameliorate Insulin Resistance, Oxidative Stress, Inflammation and Other Metabolic Abnormalities in High-Fat/High-Fructose-Fed Rats
    Quan Zhao, Linhai Li, Yu Mei Zhu, Dezhi Hou, Yuejin Li, Xiaodong Guo, Yongzhi Wang, Opeyemi Joshua Olatunji, Ping Wan, Kunmei Gong · 2020 · Diabetes Metabolic Syndrome and Obesity
20. Role of mitochondria in pathogenesis of type 2 diabetes mellitus
    Pankaj Prasun · 2020 · Journal of Diabetes & Metabolic Disorders
21. β-Cell Dysfunction, Hepatic Lipid Metabolism, and Cardiovascular Health in Type 2 Diabetes: New Directions of Research and Novel Therapeutic Strategies
    Ahmad H. Al-Mrabeh · 2021 · Biomedicines
22. Intervention with isoleucine or valine corrects hyperinsulinemia and reduces intrahepatic diacylglycerols, liver steatosis, and inflammation in Ldlr−/−.Leiden mice with manifest obesity‐associated NASH
    Eveline Gart, Wim van Duyvenvoorde, Martien P. M. Caspers, Nikki van Trigt, Jessica M. Snabel, Aswin L. Menke, Jaap Keijer, Kanita Salic, Martine C. Morrison, Robert Kleemann · 2022 · The FASEB Journal
23. Krill Oil Supplementation Reduces Exacerbated Hepatic Steatosis Induced by Thermoneutral Housing in Mice with Diet-Induced Obesity
    Gabriella Sistilli, Veronika Kalendová, Tomáš Čajka, Illaria Irodenko, Kristina Bardová, Marina Oseeva, Petr Žáček, Petra Kroupova, Olga Horakova, Karoline Lackner et al. · 2021 · Nutrients
24. Phytochemicals: Targeting Mitophagy to Treat Metabolic Disorders
    Zuqing Su, Yanru Guo, Xiufang Huang, Bing Cheng Feng, Lipeng Tang, Guangjuan Zheng, Ying Jian Zhu · 2021 · Frontiers in Cell and Developmental Biology
25. Lipid Metabolism–Signaling Crosstalk in Metabolic Disease and Aging: Mechanisms and Therapeutic Targets
    Paalki Sethi, Awdhesh Kumar Mishra, Shampa Ghosh, Dr. Krishna Kumar Singh, Samarth Sharma, Radoslav Stojchevski, Dimiter Bogdanov Avtanski, Jitendra Kumar Sinha · 2025 · Nutrients
26. Combined genetic deletion of GDF15 and FGF21 has modest effects on body weight, hepatic steatosis and insulin resistance in high fat fed mice
    Satish Patel, Afreen Haider, Anna Álvarez-Guaita, Guillaume Bidault, Julia S. El-Sayed Moustafa, Esther Guiu‐Jurado, John A. Tadross, James Warner, James Harrison, Sam Virtue et al. · 2022 · Molecular Metabolism
27. Plasma cathepsin D activity is negatively associated with hepatic insulin sensitivity in overweight and obese humans
    Lingling Ding, Gijs H. Goossens, Yvonne Oligschlaeger, Tom Houben, Ellen E. Blaak, Ronit Shiri‐Sverdlov · 2019 · Diabetologia
28. Lipidomics perturbations in the brain of adult zebrafish (Danio rerio) after exposure to chiral ibuprofen
    Wei Zhang, Yue Song, Tingting Chai, Guangqin Liao, Lin Zhang, Qi Jia, Yongzhong Qian, Jing Yi Qiu · 2020 · The Science of The Total Environment
29. The metabolic syndrome, thiazolidinediones, and implications for intersection of chronic and inflammatory disease
    Jerry R. Colca, Philipp E. Scherer · 2021 · Molecular Metabolism
30. Ceramide synthesis inhibitors prevent lipid-induced insulin resistance through the DAG-PKCε-insulin receptorT1150 phosphorylation pathway
    Weiwei Xu, Dongyan Zhang, Yumin Ma, Rafael Calais Gaspar, Mario Kahn, Ali R. Nasiri, Sue Murray, Varman T. Samuel, Gerald I. Shulman · 2024 · Cell Reports
31. Postprandial Plasma Lipidomics Reveal Specific Alteration of Hepatic-derived Diacylglycerols in Nonalcoholic Fatty Liver Disease
    Thomas J. Velenosi, Gil Ben Yakov, Maren Catherina Podszun, Julian Hercun, Ohad Etzion, Shanna B. Yang, Cathy Nadal, Vanessa Haynes–Williams, Wen‐Chun A. Huang, Lila González-Hódar et al. · 2022 · Gastroenterology
32. Increased levels of inflammatory plasma markers and obesity risk in a mouse model of Down syndrome
    Marta Fructuoso, Latif Rachdi, Erwann Philippe, R Denis, Chr̀istophe Magnan, Hervé Le Stunff, Nathalie Janel, Mara Dierssen · 2017 · Free Radical Biology and Medicine
33. Micro-RNA-27a/b negatively regulates hepatic gluconeogenesis by targeting FOXO1
    Shuyue Wang, Huihan Ai, Lei Liu, Xiaojun Zhang, Feng Gao, Lihua Zheng, Jingwen Yi, Luguo Sun, Chunlei Yu, Huiying Zhao et al. · 2019 · American Journal of Physiology-Endocrinology and Metabolism
34. Mediterranean Diet: The Beneficial Effects of Lycopene in Non-Alcoholic Fatty Liver Disease
    Ludovico Abenavoli, Anna Caterina Procopio, Maria Rosaria Paravati, Giosuè Costa, Nataša Milić, Stefano Alcaro, Francesco Luzza · 2022 · Journal of Clinical Medicine
35. Defining lipid mediators of insulin resistance: controversies and challenges
    Louise K. Metcalfe, Greg C. Smith, Nigel A. Turner · 2018 · Journal of Molecular Endocrinology
36. Pathogenesis and remission of type 2 diabetes: what has the twin cycle hypothesis taught us?
    Ahmad H. Al-Mrabeh · 2020 · Cardiovascular Endocrinology & Metabolism
37. Oligonucleotide therapies for nonalcoholic steatohepatitis
    Sixu Li, Feng Xiong, Songbo Zhang, Jinghua Liu, Guangping Gao, Jun Hua Xie, Yi Wang · 2024 · Molecular Therapy — Nucleic Acids
38. Genetic, dietary, and sex-specific regulation of hepatic ceramides and the relationship between hepatic ceramides and IR [S]
    Frode Norheim, Thomas Bjellaas, Simon T. Y. Hui, Karthickeyan Chella Krishnan, Jakleen J. Lee, Sonul Gupta, Calvin Pan, Yehudit Hasin-Brumshtein, Brian W. Parks, D. Li et al. · 2018 · Journal of Lipid Research
39. Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated With Nonalcoholic Fatty Liver Disease
    Mirella Pastore, Stefania Grimaudo, Rosaria Maria Pipitone, Giulia Lori, Chiara Raggi, Salvatore Petta, Fabio Marra · 2019 · Frontiers in Pharmacology
40. Ginsenoside Rg1 ameliorates palmitic acid-induced insulin resistance in HepG2 cells in association with modulating Akt and JNK activity
    Jiao Mo, Yulin Zhou, Renhua Yang, Pengli Zhang, Bo He, Jianyu Yang, Shu-De Li, Zhiqiang Shen, Peng Chen · 2019 · Pharmacological Reports
41. Roles of GPRC5 family proteins: focusing on GPRC5B and lipid-mediated signalling
    Yoshio Hirabayashi, Yeon‐Jeong Kim · 2020 · The Journal of Biochemistry
42. Role of Sphingosine Kinase in Type 2 Diabetes Mellitus
    Yanfei Qi, Wei Wang, Ziyu Song, Gulibositan Aji, Xin Tracy Liu, Pu Xia · 2021 · Frontiers in Endocrinology
43. Characteristics and molecular mechanisms through which SGLT2 inhibitors improve metabolic diseases: A mechanism review
    Lingli Xie, Xia Wenfang · 2022 · Life Sciences
44. Protocatechuic Acid Ameliorates High Fat Diet‐Induced Obesity and Insulin Resistance in Mice
    Yuyao Xiang, Ruo-Lan Huang, Yongliang Wang, Shan-Shan Han, Xiaochen Qin, Zhenzhen Li, Xu Wang, Yuqing Han, Tao Wang, Bo Xia et al. · 2022 · Molecular Nutrition & Food Research
45. Germ-Free Swiss Webster Mice on a High-Fat Diet Develop Obesity, Hyperglycemia, and Dyslipidemia
    Isabelle E. Logan, Gerd Bobe, Cristobal L. Miranda, Stephany Vasquez‐Perez, Jaewoo Choi, Malcolm B. Lowry, Thomas J. Sharpton, Andrey Morgun, Claudia S. Maier, Jan Frederik Stevens et al. · 2020 · Microorganisms
46. Hepatocyte NLRP3 interacts with PKCε to drive hepatic insulin resistance and steatosis
    Weiwei Qin, Jianping Weng · 2023 · 中国科学通报：英文版
47. From lipids to glucose: Investigating the role of dyslipidemia in the risk of insulin resistance
    Mahtab Jahdkaran, Mohammad Sistanizad · 2025 · The Journal of Steroid Biochemistry and Molecular Biology
48. Role of ceramide-to-dihydroceramide ratios for insulin resistance and non-alcoholic fatty liver disease in humans
    Maria Apostolopoulou, Ruth Gordillo, Sofiya Gancheva, Klaus Straßburger, Christian Herder, Iréne Esposito, Matthias Schlensak, Philipp E. Scherer, Michael Roden · 2020 · BMJ Open Diabetes Research & Care
49. Distinct subcellular localisation of intramyocellular lipids and reduced PKCε/PKCθ activity preserve muscle insulin sensitivity in exercise-trained mice
    Rafael Calais Gaspar, Kun Lyu, Brandon T. Hubbard, Brooks P. Leitner, Panu K. Luukkonen, Sandro Massao Hirabara, Ikki Sakuma, Ali R. Nasiri, Dongyan Zhang, Mario Kahn et al. · 2022 · Diabetologia
50. FoxO1 Is Required for Most of the Metabolic and Hormonal Perturbations Produced by Hepatic Insulin Receptor Deletion in Male Mice
    Alisha V. Ling, Mary E. Gearing, Ivana Semova, Dong‐Ju Shin, Rebecca L. Clements, Zon Weng Lai, Sudha B. Biddinger · 2017 · Endocrinology
51. Mitochondrial Uncoupling Coordinated With PDH Activation Safely Ameliorates Hyperglycemia via Promoting Glucose Oxidation
    Haowen Jiang, Jia Jin, Yanan Duan, Zhifu Xie, Yufeng Li, Anhui Gao, Min Gu, Xinwen Zhang, Chang Si Peng, Chunmei Xia et al. · 2019 · Diabetes
52. Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches
    Angelo Armandi, Jörn Markus Schattenberg · 2021 · Nutrients
53. Role of hepatic lipid species in the progression of nonalcoholic fatty liver disease
    Ke‐Qiong Deng, Xuewei Huang, Fang Lei, Xiao‐Jing Zhang, Peng Zhang, Zhi‐Gang She, Jingjing Cai, Yan‐Xiao Ji, Hongliang Li · 2022 · American Journal of Physiology-Cell Physiology
54. Relationships between very low-density lipoproteins-ceramides, -diacylglycerols, and -triacylglycerols in insulin-resistant men
    Mucinski, Justine M., Manrique‐Acevedo, Camila, Kasumov, Takhar, Garrett, Timothy J., Gaballah, Ayman, Parks, Elizabeth J. · 2020 · Lipids
55. Impaired ferritinophagy flux induced by high fat diet mediates hepatic insulin resistance via endoplasmic reticulum stress
    Chunjie Jiang, Shanshan Zhang, Dan Li, Li Chen, Ying Zhao, Guibin Mei, Jingjing Liu, Yuhan Tang, Chao Gao, Ping Yao · 2020 · Food and Chemical Toxicology
56. Lipid metabolism disorders contribute to the pathogenesis of Hepatospora eriocheir in the crab Eriocheir sinensis
    Zhengfeng Ding · 2020 · Journal of Fish Diseases
57. Ufmylation on UFBP1 alleviates non-alcoholic fatty liver disease by modulating hepatic endoplasmic reticulum stress
    Ziming Mao, Xiaowen Ma, Yu Jing, Minyan Shen, Xirui Ma, Jing Zhu, Huifang Liu, Guangya Zhang, Fengling Chen · 2023 · Cell Death and Disease
58. A high fat diet with a high C18:0/C16:0 ratio induced worse metabolic and transcriptomic profiles in C57BL/6 mice
    Liqiang Wang, Fei Xu, Zhenfeng Song, Dan Han, Jingyi Zhang, Linjun Chen, Lixin Na · 2020 · Lipids in Health and Disease
59. Maternal plasma diacylglycerols and triacylglycerols in the prediction of gestational diabetes mellitus
    Guixue Hou, Ya Ming Gao, Liona C. Poon, Yan Ren, Chunwei Zeng, Bo Wen, Argyro Syngelaki, Liang Lin, Jin Zi, Fengxia Su et al. · 2022 · BJOG An International Journal of Obstetrics & Gynaecology
60. The circadian rhythm: an influential soundtrack in the diabetes story
    Amirali Hariri, Mina Mirian, Ali Zarrabi, Mohammad Kohandel, Maryam Amini-Pozveh, Amir Reza Aref, Aliye Tabatabaee, Pranav Kumar Prabhakar, Ponnurengam Malliappan Sivakumar · 2023 · Frontiers in Endocrinology
61. Exercise Is Medicine for Nonalcoholic Fatty Liver Disease: Exploration of Putative Mechanisms
    Heinle, James Westley, DiJoseph, Kara, Sabag, Angelo, Oh, Sechang, Kimball, Scot R., Keating, Shelley, Stine, Jonathan G. · 2023 · Nutrients
62. Exercise decreases CLK2 in the liver of obese mice and prevents hepatic fat accumulation
    Vítor Rosetto Muñoz, Rafael Calais Gaspar, Gabriel Keine Kuga, Susana Castelo Branco Ramos Nakandakari, Igor L. Baptista, Rania A. Mekary, Adelino Sánchez Ramos da Silva, Leandro Pereira de Moura, Eduardo Rochete Ropelle, Dennys E. Cintra et al. · 2018 · Journal of Cellular Biochemistry
63. Transcriptional Regulation of Early Growth Response Gene-1 (EGR1) is Associated with Progression of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients with Insulin Resistance
    Zedong Li, Yu Peng, Jia‐Jia Wu, Tao Fang, Jun Zhou · 2019 · Medical Science Monitor
64. Role of anatomical location, cellular phenotype and perfusion of adipose tissue in intermediary metabolism: A narrative review
    Stefania Camastra, Ele Ferrannini · 2022 · Reviews in Endocrine and Metabolic Disorders
65. The Human Milk Oligosaccharide 2′-Fucosyllactose Alleviates Liver Steatosis, ER Stress and Insulin Resistance by Reducing Hepatic Diacylglycerols and Improved Gut Permeability in Obese Ldlr-/-.Leiden Mice
    Eveline Gart, Kanita Salic, Martine C. Morrison, Martin A. Giera, Joline Attema, Christa de Ruiter, Martien P. M. Caspers, Frank H. J. Schuren, Ivana Bobeldijk‐Pastorova, Marianne Heer et al. · 2022 · Frontiers in Nutrition
66. Current understanding on pathogenesis and effective treatment of glycogen storage disease type Ib with empagliflozin: new insights coming from diabetes for its potential implications in other metabolic disorders
    Arianna Maiorana, Francesco Tagliaferri, Carlo Dionisi‐Vici · 2023 · Frontiers in Endocrinology
67. Strong Heart, Low Ceramides
    William L. Holland, Scott A. Summers · 2018 · Diabetes
68. Omega‐3 phospholipids and obesity‐associated NAFLD: Potential mechanisms and therapeutic perspectives
    Marko Mitrovic, Gabriella Sistilli, Olga Horakova, Martin Rossmeisl · 2021 · European Journal of Clinical Investigation
69. Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
    Daniela Maria Tănase, Evelina Maria Gosav, Daniela Petrov, Alina Ecaterina Jucan, Cristina-Mihaela Lăcătușu, Mariana Floria, Claudia Cristina Tărniceriu, Claudia Florida Costea, Manuela Ciocoiu, Ciprian Rezuș · 2021 · Diagnostics
70. Novel Insights into the Adipokinome of Obese and Obese/Diabetic Mouse Models
    Birgit Knebel, Simon Goeddeke, Gereon Poschmann, Daniel F. Markgraf, Sylvia Jacob, Ulrike Nitzgen, Waltraud Paßlack, Christina Preuss, Hans-Dieter Dicken, Kai Stühler et al. · 2017 · International Journal of Molecular Sciences
71. The Influence of Coumestrol on Sphingolipid Signaling Pathway and Insulin Resistance Development in Primary Rat Hepatocytes
    Hubert Żywno, Wiktor Bzdęga, Adrian Kołakowski, Piotr Franciszek Kurzyna, Ewa Harasim‐Symbor, Klaudia Sztolsztener, Adrian Chabowski, Karolina Konstantynowicz-Nowicka · 2021 · Biomolecules
72. Deficiency in the short‐chain acyl‐CoA dehydrogenase protects mice against diet‐induced obesity and insulin resistance
    Yulong Chen, Jinglu Chen, Cai‐Xia Zhang, Shanshan Yang, Xueping Zhang, Yin Liu, Zhiguang Su · 2019 · The FASEB Journal
73. Review article: Hepatic steatosis and its associations with acute and chronic liver diseases
    Aaron B. Koenig, Albert Tan, Hala Abdelaal, Fanny Monge, Zobair M. Younossi, Zachary D Goodman · 2024 · Alimentary Pharmacology & Therapeutics
74. Characterization of the Plasma Lipidome in Dairy Cattle Transitioning from Gestation to Lactation: Identifying Novel Biomarkers of Metabolic Impairment
    Jorge Eduardo Rico, S. Saed Samii, Yu Zang, Pragney Deme, Norman J. Haughey, Ester Grilli, J.W. McFadden · 2021 · Metabolites
75. Serum C18:1-Cer as a Potential Biomarker for Early Detection of Gestational Diabetes
    Ilona Juchnicka, Mariusz Kuźmicki, Piotr Zabielski, Adam Jacek Kretowski, Agnieszka Urszula Błachnio-Zabielska, Jacek Szamatowicz · 2022 · Journal of Clinical Medicine
76. Lipidomics in gestational diabetes mellitus
    Yi Wang, Xiong‐Fei Pan, An Pan · 2022 · Current Opinion in Lipidology
77. Hypothalamic hormone-sensitive lipase regulates appetite and energy homeostasis
    Cecilie Hundahl, Petra Kotzbeck, Hayley B. Burm, Søren Hofman Christiansen, Lola Torz, Aske W. Helge, Martin P. Madsen, Cecilia Ratner, Annette Karen Serup, Jonatan J. Thompson et al. · 2021 · Molecular Metabolism
78. NLRP3 inflammasome blocked the glycolytic pathway via targeting to PKLR in arsenic-induced hepatic insulin resistance
    Jingyuan Zhang, Tianming Qiu, Liping Jiang, Ningning Wang, Yuhan Zhu, Rushan Yan, Shengyu Wang, Jie Bai, Xiaoxia Shi, Guang Yang et al. · 2021 · Ecotoxicology and Environmental Safety
79. A CDAHFD-induced mouse model mimicking human NASH in the metabolism of hepatic phosphatidylcholines and acyl carnitines
    Jie Yang, Manyun Dai, Ying Wang, Zheng Yan, Shuqi Mao, Aiming Liu, Caide Lu · 2024 · Food & Function
80. Molecular Regulation and Therapeutic Targeting of VLDL Production in Cardiometabolic Disease
    Kendall H. Burks, Nathan O. Stitziel, Nicholas O. Davidson · 2024 · Cellular and Molecular Gastroenterology and Hepatology
81. The bile acid profile
    Zhenhua Liu, Chongge You · 2024 · Clinica Chimica Acta
82. Therapeutic potential of sulforaphane in liver diseases: a review
    Yan Liang, Yachun Yan · 2023 · Frontiers in Pharmacology
83. Short-Term Strength Exercise Reduces Hepatic Insulin Resistance in Obese Mice by Reducing PTP1B Content, Regardless of Changes in Body Weight
    Kellen Cristina da Cruz Rodrigues, Rodrigo Martins Pereira, Guilherme Francisco Peruca, Lucas Wesley Torres Barbosa, Marcella Ramos Sant’Ana, Vítor Rosetto Muñoz, Ana Paula Morelli, Fernando Moreira Simabuco, Adelino Sánchez Ramos da Silva, Dennys E. Cintra et al. · 2021 · International Journal of Molecular Sciences
84. Palmitoleic acid on top of HFD ameliorates insulin resistance independent of diacylglycerols and alters gut microbiota in C57BL/6J mice
    Qijian Liang, Yan Zheng, Fanli Meng, Xiaofan Jiang, Qingcai Zhen, Zhongting Lu, Shixiu Zhang, Lei Du, Hao Wu, Xin Guo · 2023 · Food Science and Human Wellness
85. Liver and obesity: a narrative review
    Amedeo Lonardo, Ralf Weiskirchen · 2025 · Exploration of Medicine
86. Tissue-specific inflammation and insulin sensitivity in subjects with obesity
    Sabrina M. Oussaada, Murat Kiliçarslan, Barbara A. de Weijer, Pim W. Gilijamse, Aydın Şekercan, Sam Virtue, Ignace M. C. Janssen, Arnold W. J. M. van de Laar, Ahmet Demirkıran, Bart A. van Wagensveld et al. · 2024 · Diabetes Research and Clinical Practice
87. Resveratrol metabolites ameliorate insulin resistance in HepG2 hepatocytes by modulating IRS-1/AMPK
    Wendi Teng, Wenjing Yin, Liang Zhao, Changwei Ma, Jiaqiang Huang, Fazheng Ren · 2018 · RSC Advances
88. Moderate-intensity Combined Training Induces Lipidomic Changes in Individuals With Obesity and Type 2 Diabetes
    Renata Garbellini Duft, Ivan Luiz Padilha Bonfante, Susana Alejandra Palma-Duran, Mara Patrícia Traina Chacon‐Mikahil, Julian Leether Griffin, Cláudia Regina Cavaglieri · 2024 · The Journal of Clinical Endocrinology & Metabolism
89. Review: Welfare in farm animals from an animal-centred point of view
    Korinna Huber · 2024 · animal
90. The role of protein kinase D (PKD) in intracellular nutrient sensing and regulation of adaptive responses to the obese environment
    Mark C. Renton, S. McGee, Kirsten F. Howlett · 2020 · Obesity Reviews
91. Mitochondrial uncoupler SHC517 reverses obesity in mice without affecting food intake
    Sing-Young Chen, Martina Beretta, Stephanie J. Alexopoulos, Divya P. Shah, Ellen M. Olzomer, Stefan R. Hargett, Elizabeth S. Childress, Joseph M. Salamoun, Isabella Aleksovska, Ariane Roseblade et al. · 2021 · Metabolism
92. Distinct infrastructure of lipid networks in visceral and subcutaneous adipose tissues in overweight humans
    Anish Zacharia, Daniel Menezes Saidemberg, Chanchal Thomas Mannully, Natalya M. Kogan, Alaa Shehadeh, Reut Sinai, Avigail Zucker, Reut Bruck‐Haimson, Nir Goldstein, Yulia Haim et al. · 2020 · American Journal of Clinical Nutrition
93. A pilot study optimizing metabolomic and lipidomic acquisition in serum for biomarker discovery in nonalcoholic fatty liver disease
    Dandan He, Yang Su, Duanyue Meng, Xinmiao Wang, Jun Wang, Hui Ye · 2021 · Journal of Mass Spectrometry and Advances in the Clinical Lab
94. Molecular mechanisms of metabolic dysfunction-associated steatotic liver disease (MASLD): functional analysis of glucose and fructose metabolism pathways
    Naila Rabbani, Paul John Thornalley · 2025 · Clinical Science
95. Association of non-high-density lipoprotein cholesterol trajectories with the development of non-alcoholic fatty liver disease: an epidemiological and genome-wide association study
    Jun-Hyuk Lee, Jiyeon Kim, Jung Oh Kim, Yu-Jin Kwon · 2023 · Journal of Translational Medicine
96. Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
    Kamlesh K. Bhopale, Mukund P. Srinivasan · 2023 · Livers
97. Hyperinsulinaemia: does it tip the balance toward intrahepatic fat accumulation?
    Leanne Hodson, Fredrik Karpe · 2019 · Endocrine Connections
98. Metabolic Imaging in Non-Alcoholic Fatty Liver Disease: Applications of Magnetic Resonance Spectroscopy
    Prarthana Thiagarajan, Stephen Bawden, Guruprasad Padur Aithal · 2021 · Journal of Clinical Medicine
99. The Pivotal Role of the Western Diet, Hyperinsulinemia, Ectopic Fat, and Diacylglycerol-Mediated Insulin Resistance in Type 2 Diabetes
    J. A. M. J. L. Janssen · 2025 · International Journal of Molecular Sciences
100. MicroRNA-34a Mediates High-Fat-Induced Hepatic Insulin Resistance by Targeting ENO3
     Yuanyuan Wang, Xue Zhao, Liuchao Zhang, Chunxiao Yang, Kening Zhang, Zhuo Gu, Haiyan Ding, Shuangshuang Li, Jian Qin, Xia Chu · 2023 · Nutrients